SCHEMBL8078005

SCHEMBL8078005

CC(C)(C)c1cc(CCC(=O)Nc2ccc(Nc3ccccc3)cc2)cc(C(C)(C)C)c1O

nearest known ligand 0.59

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
GAA P10253 7/20 0.59
MAPT P10636 6/20 0.56
HTT P42858 2/20 0.56
ALDH1A1 P00352 2/20 0.56
HPGD P15428 2/20 0.56
LMNA P02545 1/20 0.56
AGTR1 P30556 1/20 0.56
SMN1; SMN2 Q16637 1/20 0.56
KMT2A Q03164 2/20 0.55
RAB9A P51151 2/20 0.55
MEN1 O00255 1/20 0.54
MAOB P27338 3/20 0.53
MAOA P21397 2/20 0.53
TOP2A P11388 1/20 0.50
TOP2B Q02880 1/20 0.50
ACHE P22303 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8515760 0.95 GAA (0.65) GAAMAPTHTTALDH1A1LMNA
SCHEMBL20390741 0.91 GAA (0.70) GAAMAPTHTTALDH1A1LMNA
SCHEMBL31072419 0.90 GAA (0.59) GAAMAPTHTTALDH1A1HPGD
SCHEMBL784951 0.87 GAA (0.65) GAAMAPTHTTALDH1A1LMNA
SCHEMBL16748398 0.86 GAA (0.45) GAAMAPTHTTALDH1A1HPGD
SCHEMBL785327 0.86 GAA (0.54) GAAMAPTHTTALDH1A1LMNA
SCHEMBL4569551 0.85 GAA (0.63) GAAHTTALDH1A1LMNAAGTR1
SCHEMBL8723466 0.85 MAPT (0.60) GAAMAPTHTTALDH1A1LMNA
SCHEMBL20808585 0.85 KMT2A (0.65) GAAMAPTHTTALDH1A1LMNA
SCHEMBL20345019 0.84 HTT (0.52) GAAMAPTHTTALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1030832-A2 ORGANIC MATERIALS STABILIZED BY COMPOUNDS CONTAINING BOTH AMINE AND HINDERED PHENOL FUNCTIONALITIES UNIROYAL CHEMICAL COMPANY, Inc. (US) 2000-08-30 EP claimed
WO-1999020686-A2 ORGANIC MATERIALS STABILIZED BY COMPOUNDS CONTAINING BOTH AMINE AND HINDERED PHENOL FUNCTIONALITIES UNIROYAL CHEMICAL COMPANY, INC. (US) 1999-04-29 WO claimed
US-5834544-A Organic materials stabilized by compounds containing both amine and hindered phenol functional functionalities UNIROYAL CHEMICAL COMPANY, INC. (US) 1998-11-10 US claimed
EP-3071544-B1 MACROMOLECULAR ANTIOXIDANTS BASED ON DUAL TYPE MOIETY PER MOLECULE: STRUCTURES METHODS OF MAKING AND USING THE SAME POLNOX CORP (US) 2022-07-06 EP disclosed
EP-3071544-B1 MACROMOLECULAR ANTIOXIDANTS BASED ON DUAL TYPE MOIETY PER MOLECULE: STRUCTURES METHODS OF MAKING AND USING THE SAME POLNOX CORP (US) 2022-07-06 EP disclosed
US-11060027-B2 Macromolecular antioxidants based on dual type moiety per molecule: structures, methods of making and using the same POLNOX CORPORATION (US) 2021-07-13 US disclosed
US-20200392406-A1 MACROMOLECULAR ANTIOXIDANTS BASED ON DUAL TYPE MOIETY PER MOLECULE: STRUCTURES, METHODS OF MAKING AND USING THE SAME POLNOX CORPORATION 2020-12-17 US disclosed
US-10683455-B2 Macromolecular antioxidants based on dual type moiety per molecule: structures, methods of making and using the same POLNOX CORPORATION (US) 2020-06-16 US disclosed
US-10683455-B2 Macromolecular antioxidants based on dual type moiety per molecule: structures, methods of making and using the same POLNOX CORPORATION (US) 2020-06-16 US disclosed
US-20190292454-A1 Macromolecular Antioxidants Based On Dual Type Moiety Per Molecule: Structures, Methods Of Making And Using The Same POLNOX CORPORATION 2019-09-26 US disclosed
US-20190292454-A1 Macromolecular Antioxidants Based On Dual Type Moiety Per Molecule: Structures, Methods Of Making And Using The Same POLNOX CORPORATION 2019-09-26 US disclosed
US-10294423-B2 Macromolecular antioxidants based on dual type moiety per molecule: structures, methods of making and using the same POLNOX CORPORATION (US) 2019-05-21 US disclosed
US-20160289558-A1 Macromolecular Antioxidants Based On Dual Type Moiety Per Molecule: Structures, Methods Of Making And Using The Same POLNOX CORPORATION (US) 2016-10-06 US disclosed
US-20160289558-A1 Macromolecular Antioxidants Based On Dual Type Moiety Per Molecule: Structures, Methods Of Making And Using The Same POLNOX CORPORATION (US) 2016-10-06 US disclosed
US-20160289558-A1 Macromolecular Antioxidants Based On Dual Type Moiety Per Molecule: Structures, Methods Of Making And Using The Same POLNOX CORPORATION (US) 2016-10-06 US disclosed
EP-3071544-A2 MACROMOLECULAR ANTIOXIDANTS BASED ON DUAL TYPE MOIETY PER MOLECULE: STRUCTURES METHODS OF MAKING AND USING THE SAME Polnox Corporation (US) 2016-09-28 EP disclosed
WO-2015077635-A2 MACROMOLECULAR ANTIOXIDANTS BASED ON DUAL TYPE MOIETY PER MOLECULE: STRUCTURES METHODS OF MAKING AND USING THE SAME POLNOX CORPORATION (US) 2015-05-28 WO disclosed
EP-1030832-A2 ORGANIC MATERIALS STABILIZED BY COMPOUNDS CONTAINING BOTH AMINE AND HINDERED PHENOL FUNCTIONALITIES UNIROYAL CHEMICAL COMPANY, Inc. (US) 2000-08-30 EP disclosed
WO-1999020686-A2 ORGANIC MATERIALS STABILIZED BY COMPOUNDS CONTAINING BOTH AMINE AND HINDERED PHENOL FUNCTIONALITIES UNIROYAL CHEMICAL COMPANY, INC. (US) 1999-04-29 WO disclosed
US-5834544-A Organic materials stabilized by compounds containing both amine and hindered phenol functional functionalities UNIROYAL CHEMICAL COMPANY, INC. (US) 1998-11-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11060027-B2 Macromolecular antioxidants based on dual type moiety per molecule: structures, methods of making and using the same LPO, GPX4, DUOX2 GAA 1034/4885MAPT 2287/4885HTT 1761/4885
US-10683455-B2 Macromolecular antioxidants based on dual type moiety per molecule: structures, methods of making and using the same LPO, GPX4, DUOX2 GAA 1034/4885MAPT 2287/4885HTT 1761/4885
US-20160289558-A1 Macromolecular Antioxidants Based On Dual Type Moiety Per Molecule: Structures, Methods Of Making And Using The Same LPO, GPX4, DUOX2 GAA 1016/4885MAPT 2179/4885HTT 1601/4885
US-20190292454-A1 Macromolecular Antioxidants Based On Dual Type Moiety Per Molecule: Structures, Methods Of Making And Using The Same LPO, GPX4, DUOX2 GAA 1034/4885MAPT 2287/4885HTT 1761/4885
US-20200392406-A1 MACROMOLECULAR ANTIOXIDANTS BASED ON DUAL TYPE MOIETY PER MOLECULE: STRUCTURES, METHODS OF MAKING AND USING THE SAME LPO, GPX4, DUOX2 GAA 1034/4885MAPT 2287/4885HTT 1761/4885
US-10294423-B2 Macromolecular antioxidants based on dual type moiety per molecule: structures, methods of making and using the same LPO, GPX4, DUOX2 GAA 1016/4885MAPT 2179/4885HTT 1601/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.